Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

The presence of 19-kDa Bcl-2 in dividing cells.

Hoetelmans RW, Van de Velde CJ, Van Dierendonck JH.

Cell Prolif. 2003 Dec;36(6):293-306.

PMID:
14710848
2.

Bcl-2 overexpression does not prevent but retards adriamycin toxicity in CC531 colon carcinoma cells.

Hoetelmans RW, Vahrmeijer AL, Mulder GJ, van de Velde CJ, Nagelkerke JF, van Dierendonck JH.

Chemotherapy. 2003 Dec;49(6):309-15.

PMID:
14671432
3.

Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene.

van der Eb MM, Geutskens SB, van Kuilenburg AB, van Lenthe H, van Dierendonck JH, Kuppen PJ, van Ormondt H, van de Velde CJ, Wanders RJ, van Gennip AH, Hoeben RC.

J Gene Med. 2003 Dec;5(12):1018-27.

PMID:
14661177
4.

The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain.

Hoetelmans RW, Vahrmeijer AL, van Vlierberghe RL, Keijzer R, van de Velde CJ, Mulder GJ, Van Dierendonck JH.

Cell Prolif. 2003 Feb;36(1):35-44.

PMID:
12558659
5.

Comparison of the effects of microwave heating and high pressure cooking for antigen retrieval of human and rat Bc1-2 protein in formaldehyde-fixed, paraffin-embedded sections.

Hoetelmans RW, van Slooten HJ, Keijzer R, van de Velde CJ, van Dierendonck JH.

Biotech Histochem. 2002 May;77(3):137-44.

PMID:
12229934
6.

DNA damage detection using DNA polymerase I or its Klenow fragment. Applicability, specificity, limitations.

van Dierendonck JH.

Methods Mol Biol. 2002;203:81-108. Review. No abstract available.

PMID:
12073456
7.

Effects of acetone, methanol, or paraformaldehyde on cellular structure, visualized by reflection contrast microscopy and transmission and scanning electron microscopy.

Hoetelmans RW, Prins FA, Cornelese-ten Velde I, van der Meer J, van de Velde CJ, van Dierendonck JH.

Appl Immunohistochem Mol Morphol. 2001 Dec;9(4):346-51.

PMID:
11759062
8.

Routine formaldehyde fixation irreversibly reduces immunoreactivity of Bcl-2 in the nuclear compartment of breast cancer cells, but not in the cytoplasm.

Hoetelmans RW, van Slooten HJ, Keijzer R, van de Velde CJ, van Dierendonck JH.

Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):74-80.

PMID:
11277419
9.

Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.

Vahrmeijer AL, Hoetelmans RW, Mulder GJ, Schutrups J, van Vlierberghe RL, van de Velde CJ, van Dierendonck JH.

Biochem Pharmacol. 2000 Jun 15;59(12):1557-62.

PMID:
10799652
10.

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.

Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ.

Br J Cancer. 2000 May;82(9):1539-46.

11.

[The TUNEL technic for demonstrating apoptosis on paraffin sections].

Popovska S, van Dierendonck JH, Baĭchev G, Deliĭski T.

Akush Ginekol (Sofiia). 1999;38(2):37-9. Bulgarian.

PMID:
10730386
12.

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.

van Slooten HJ, van De Vijver MJ, Borresen AL, Eyfjörd JE, Valgardsdóttir R, Scherneck S, Nesland JM, Devilee P, Cornelisse CJ, van Dierendonck JH.

J Pathol. 1999 Dec;189(4):504-13.

PMID:
10629550
13.

Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.

Pietersen AM, van der Eb MM, Rademaker HJ, van den Wollenberg DJ, Rabelink MJ, Kuppen PJ, van Dierendonck JH, van Ormondt H, Masman D, van de Velde CJ, van der Eb AJ, Hoeben RC, Noteborn MH.

Gene Ther. 1999 May;6(5):882-92.

14.

Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ.

Biochem Pharmacol. 1999 Aug 15;58(4):655-64.

PMID:
10413303
16.

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH.

Br J Cancer. 1998 Jun;77(11):1842-7.

17.

X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.

van der Houven van Oordt CW, Schouten TG, van Krieken JH, van Dierendonck JH, van der Eb AJ, Breuer ML.

Carcinogenesis. 1998 May;19(5):847-53.

PMID:
9635873
18.

Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases.

Rovers JP, Schuitmaker JJ, Vahrmeijer AL, van Dierendonck JH, Terpstra OT.

Br J Cancer. 1998 Jun;77(12):2098-103.

19.

Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

Vahrmeijer AL, Van Der Eb MM, Van Dierendonck JH, Kuppen PJ, Van De Velde CJ.

Semin Surg Oncol. 1998 Apr-May;14(3):262-8. Review.

PMID:
9548610
20.

Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.

van Slooten HJ, van de Vijver MJ, van de Velde CJ, van Dierendonck JH.

Br J Cancer. 1998 Mar;77(5):789-96.

21.

In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure.

van den Eijnde SM, Luijsterburg AJ, Boshart L, De Zeeuw CI, van Dierendonck JH, Reutelingsperger CP, Vermeij-Keers C.

Cytometry. 1997 Dec 1;29(4):313-20.

PMID:
9415414
22.

Monitoring engraftment of transplanted hepatocytes in recipient liver with 5-bromo-2'-deoxyuridine.

de Roos WK, von Geusau BA, Bouwman E, van Dierendonck JH, Borel Rinkes IH, Terpstra OT.

Transplantation. 1997 Feb 27;63(4):513-8.

PMID:
9047143
23.

Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.

Vahrmeijer AL, Snel CA, Steenvoorden DP, Beijnen JH, Pang KS, Schutrups J, Tirona R, Keizer HJ, van Dierendonck JH, van de Velde CJ, Mulder GJ.

Cancer Res. 1996 Oct 15;56(20):4709-14.

24.

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ.

Br J Cancer. 1996 Jul;74(1):78-85.

25.

Effect of hormone depletion on cell survival in the EMR-86 rat mammary carcinoma.

Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJ, Elvers B, van Dierendonck JH.

Br J Cancer. 1996 May;73(10):1210-5.

26.

Microwave-enhanced in situ end-labeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain.

Lucassen PJ, Chung WC, Vermeulen JP, Van Lookeren Campagne M, Van Dierendonck JH, Swaab DF.

J Histochem Cytochem. 1995 Nov;43(11):1163-71.

PMID:
7560899
27.

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer.

van Slooten HJ, Bonsing BA, Hiller AJ, Colbern GT, van Dierendonck JH, Cornelisse CJ, Smith HS.

Br J Cancer. 1995 Jul;72(1):22-30.

28.

Treatment of colorectal cancer metastases confined to the liver.

Vahrmeijer AL, van Dierendonck JH, van de Velde CJ.

Eur J Cancer. 1995 Jul-Aug;31A(7-8):1238-42. Review.

PMID:
7577030
29.

DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.

Teske E, Rutteman GR, Kuipers-Dijkshoorn NJ, van Dierendonck JH, van Heerde P, Cornelisse CJ.

Exp Hematol. 1993 Apr;21(4):579-84.

PMID:
8462667
30.

A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.

Wijsman JH, Jonker RR, Keijzer R, van de Velde CJ, Cornelisse CJ, van Dierendonck JH.

J Histochem Cytochem. 1993 Jan;41(1):7-12.

PMID:
7678025
31.

Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.

Wijsman JH, Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ.

J Pathol. 1992 Sep;168(1):75-83.

PMID:
1360499
32.

Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion.

Marinelli A, van Dierendonck JH, van Brakel GM, Irth H, Kuppen PJ, Tjaden UR, van de Velde CJ.

Br J Cancer. 1991 Dec;64(6):1069-75.

33.

A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.

Wijsman JH, Cornelisse CJ, Keijzer R, van de Velde CJ, van Dierendonck JH.

Br J Cancer. 1991 Sep;64(3):463-8.

34.

Surgically induced cytokinetic responses in experimental rat mammary tumor models.

Van Dierendonck JH, Keijzer R, Cornelisse CJ, Van de Velde CJ.

Cancer. 1991 Aug 15;68(4):759-67.

PMID:
1855176
35.

Effectiveness of isolated liver perfusion with mitomycin C in the treatment of liver tumours of rat colorectal cancer.

Marinelli A, Dijkstra FR, van Dierendonck JH, Kuppen PJ, Cornelisse CJ, van de Velde CJ.

Br J Cancer. 1991 Jul;64(1):74-8.

36.

Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.

van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJ, Cornelisse CJ.

Am J Pathol. 1991 May;138(5):1165-72.

37.

Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.

van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ.

Cancer Res. 1989 Jun 1;49(11):2999-3006.

38.

Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes.

Verheijen R, Kuijpers HJ, van Driel R, Beck JL, van Dierendonck JH, Brakenhoff GJ, Ramaekers FC.

J Cell Sci. 1989 Apr;92 ( Pt 4):531-40.

39.

Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns.

van Dierendonck JH, Keyzer R, van de Velde CJ, Cornelisse CJ.

Cytometry. 1989 Mar;10(2):143-50.

40.

Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.

van Dierendonck JH, Cornelisse CJ, van der Linden PW, van Putten LM, van de Velde CJ.

Cancer Res. 1987 Aug 1;47(15):4093-8.

41.

B-cell colony growth of malignant and normal B-cells.

Kluin-Nelemans JC, Hakvoort HW, van Dierendonck JH, Beverstock GC, Fibbe WE, Willemze R, van Rood JJ.

Br J Cancer. 1987 Apr;55(4):397-405.

42.

Hairy cell leukemia: in-vitro proliferation and pseudo-colony formation.

Kluin-Nelemans JC, Hakvoort HW, van Dissel JT, van Dierendonck JH, Beverstock GC, Fibbe WE, Willemze R.

Leuk Res. 1987;11(10):911-21.

PMID:
3682869
43.

Flow karyotyping of human melanoma cell lines.

Arkesteijn GJ, van Dierendonck JH, Vossepoel AM, Cornelisse CJ.

Cytometry. 1986 Sep;7(5):425-30.

Supplemental Content

Loading ...
Support Center